Supplementary Figure 1 from Lung Cancers with Concomitant &lt;i&gt;EGFR&lt;/i&gt; Mutations and &lt;i&gt;ALK&lt;/i&gt; Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation